FDA Guidance on Real World Data

In December 2023 FDA Issued a final guidance document on Assessing real world data registries to support regulatory decision making  for Drug and Biological Products, which provides considerations when designing a registry or using an existing registry to support a decision about a drug’s effectiveness or safety

Learn more here